| Abstrakt: |
A recent international randomized controlled trial compared the outcomes of large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for treating intermediate-risk pulmonary embolism (PE). The study found that LBMT was superior in terms of all-cause mortality, intracranial hemorrhage, major bleeding, clinical deterioration, ICU admission, and length of stay. LBMT showed faster improvement, shorter hospital stays, and fewer readmissions compared to CDT, making it a promising intervention for PE patients. The study was funded by Inari Medical and published in Circulation, providing robust evidence for clinicians and researchers in the field. [Extracted from the article] |
